[Skip to Content]
[Skip to Content Landing]
Views 1,246
Citations 0
Invited Commentary
August 24, 2020

Private Equity, Women’s Health, and the Corporate Transformation of American Medicine

Author Affiliations
  • 1Division of Health Policy and Economics, Department of Population Health Sciences, Weill Cornell Medical College
JAMA Intern Med. Published online August 24, 2020. doi:10.1001/jamainternmed.2020.3564

In this issue of JAMA Internal Medicine, Bruch and colleagues1 inform us that during the past decade, private equity firms have acquired or invested in large numbers of obstetrician-gynecologist medical groups. Most of these acquisitions and investments occurred during the past 3 years. Given the difficulty of identifying such acquisitions and investments, it is likely that their true number is even larger than Bruch and colleagues report, despite the labor-intensive methods the authors employed to identify them.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×